Skip to main content
IMMUNOLOGY2026™ Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

  1. Home

  • Thursday, Apr 16th
    9:45 AM - 10:00 AM US ET
    Antibody-Drug Conjugates (ADCs) as Adaptors for Universal CAR T cells
    Location: 157
    Author: Elisa Ruffo, PhD (she/her/hers) – Univ. of Pittsburgh Sch. of Med.
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    10:00 AM - 10:15 AM US ET
    Decoding Histone-DNA Methylation Crosstalk in Exhausted T Cells to Enhance Immunotherapy
    Location: 157
    Author: Hazem E. Ghoneim, PhD – Ohio State Univ. Col. of Med.
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    10:15 AM - 10:30 AM US ET
    mRNA Vaccines Enhance Tumor Control and Synergize with 4-1BB Costimulatory Therapy
    Location: 157
    Author: Tanushree Dangi, PhD (she/her/hers) – Beth Israel Deaconess Medical Center, Harvard Medical School
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    10:30 AM - 10:45 AM US ET
    In situ Transglutaminase 2-mediated Crosslinking of Engineered IL-7 to the Tumor Matrix Enhances Immunotherapy and Anti-PD-1 Response
    Location: 157
    Author: Angie Chun, PhD (she/her/hers) – New York University
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    10:45 AM - 11:00 AM US ET
    Intratumoral administration of a single dose of the HEPLISAV-B Vaccine and IL-15 complexes induces tumor regression in Triple Negative Brest Cancer
    Location: 157
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    11:00 AM - 11:15 AM US ET
    Prime-Target neoantigen vaccination strategy enhances neoantigen-specific T cell immunity at the tumor microenvironment in murine cold tumor models
    Location: 157
    Author: Kou Hioki, PhD (he/him/his) – Erasmus University Medical Center
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    4:15 PM - 4:30 PM US ET
    Oncolytic HSV-1 Encoding IL-12 and Anti-PD-1 Reprograms CNS Immunity: Open-Label Study of MVR-C5252 for Safety, Tolerability, and Efficacy (PuMP)
    Location: 205
    Author: Elizabeth Owens, B.S. (she/her/hers) – Duke Univ. Sch. of Med.
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    4:30 PM - 4:45 PM US ET
    Opposing Effects of Metoclopramide and Bromocriptine on Melanoma Response to Immune Checkpoint Blockade
    Location: 205
    Author: Mark Gregory, MS – Karmanos Cancer Inst., Wayne State Univ.
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    4:45 PM - 5:00 PM US ET
    Myoglobin expression boosts T-cell metabolism and antitumor effector function
    Location: 205
    Author: Julia Werner, M.Sc. (she/her/hers) – Heinrich Heine University Düsseldorf
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    5:00 PM - 5:15 PM US ET
    Skin mites enhance virtual memory T cell responses against immune checkpoint inhibitor-resistant tumors
    Location: 205
    Author: Jihoon Oh, PhD (he/him/his) – National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    5:15 PM - 5:30 PM US ET
    Targeting glycans for cancer immunotherapy
    Location: 205
    Author: Jessica Stark, PhD (she/her/hers) – Massachusetts Institute of Technology
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Thursday, Apr 16th
    5:30 PM - 5:45 PM US ET
    Leveraging extrafollicular B cells for the treatment of solid tumors
    Location: 205
    Author: Allison Casey, BS – University of Pittsburgh
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Saturday, Apr 18th
    12:45 PM - 1:00 PM US ET
    Extracellular cAMP as a potent immune modulator promotes T cell exhaustion in chronic lymphocytic leukemia
    Location: 205
    Author: Shokrollah Elahi, MD, PhD (he/him/his) – University of Alberta
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Saturday, Apr 18th
    1:00 PM - 1:15 PM US ET
    Identification of a FoxP3-specific small molecule degrader with potent antitumor immunotherapeutic efficacy
    Location: 205
    Author: Amy Tang – Northwestern University
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Saturday, Apr 18th
    1:15 PM - 1:30 PM US ET
    Immunological targeting of the endogenous retroviral protein ERVMER34-1 in carcinomas promotes epitope spread and enhances response to PD-L1 blockade
    Location: 205
    Author: Duane H. Hamilton, PhD (he/him/his) – National Cancer Institute, Center for Cancer Research, National Institutes of Health
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Saturday, Apr 18th
    1:30 PM - 1:45 PM US ET
    A universal CD4 epitope enhances cytotoxic T-cell priming and memory in glioblastoma peptide vaccination
    Location: 205
    Author: Kelly Hotchkiss, PhD – Duke University School of Medicine
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Saturday, Apr 18th
    1:45 PM - 2:00 PM US ET
    Mouse EL4 lymphoma strains differentially respond to a loss of BCATc from T cells and αCTLA4 immunotherapy
    Location: 205
    Author: Elitsa Ananieva-Stoyanova, PhD (she/her/hers) – Des Moines University
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)
  • Saturday, Apr 18th
    2:00 PM - 2:15 PM US ET
    The role of the transcription factor Blimp-1 in T cells in anti-PD1 immunotherapy in non-small cell lung cancer
    Location: 205
    Author: Susetta Finotto, PhD (she/her/hers) – University Hospital Erlangen
    Tumor Immunology: Checkpoints, Prevention, And Treatment (TIPT)